Bridging the bench-to-bedside divide in microbiome research

References

[1] de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutrition reviews. 2012; 70(Suppl 1): S45-56.

[2] Walter J, Armet AM, Finlay BB, Shanahan F. Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents. Cell. 2020; 180: 221-232.

[3] Turjeman S, Koren O. Using the microbiome in clinical practice. Microbial Biotechnology. 2022; 15: 129-134.

[4] Turjeman S, Rozera T, Elinav E, Ianiro G, Koren O. From big data and experimental models to clinical trials: iterative strategies in microbiome research. Cell. 2025; 188: 1178-1197.

[5] Rothschild D, Leviatan S, Hanemann A, Cohen Y, Weissbrod O, Segal E. An atlas of robust microbiome associations with phenotypic traits based on large-scale cohorts from two continents. PLoS One. 2022; 17: e0265756.

[6] Asnicar F, Thomas AM, Passerini A, Waldron L, Segata N. Machine learning for microbiologists. Nat Rev Microbiol. 2024; 22: 191-205.

[7] Guzman-Rodriguez M, McDonald JAK, Hyde R, et al. Using bioreactors to study the effects of drugs on the human microbiota. Methods. 2018; 149: 31-41.

[8] Lubin JB, Green J, Maddux S, et al. Arresting microbiome development limits immune system maturation and resistance to infection in mice. Cell Host Microbe. 2023; 31: 554-570.

[9] Pinto Y, Frishman S, Turjeman S, et al. Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis. Gut. 2023; 72: 918-928.

[10] Uzan-Yulzari A, Turjeman S, Moadi L, et al. A gut reaction? The role of the microbiome in aggression. Brain Behav Immun. 2024.

[11] Baruch EN, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021; 371: 602-609.

[12] Fluhr L, Mor U, Kolodziejczyk AA, et al. Gut microbiota modulates weight gain in mice after discontinued smoke exposure. Nature. 2021; 600: 713-719.

[13] Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341: 1241214.

[14] Mocanu V, Zhang Z, Deehan EC, et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021; 27: 1272-1279.

[15] Nguyen TL, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research?. Dis Model Mech. 2015; 8: 1-16.

[16] Hugenholtz F, de Vos WM. Mouse models for human intestinal microbiota research: a critical evaluation. Cell Mol Life Sci. 2018; 75: 149-160.

[17] Khanna S, Assi M, Lee C, et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a bayesian primary analysis for the prevention of recurrent clostridioides difficile infection. Drugs. 2022; 82: 1527-1538.

[18] Aggarwal N, Breedon AME, Davis CM, Hwang IY, Chang MW. Engineering probiotics for therapeutic applications: recent examples and translational outlook. Curr Opin Biotechnol. 2020; 65: 171-179.

[19] Rosshart SP, Herz J, Vassallo BG, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019; 365.

[20] Wymore Brand M, Wannemuehler MJ, Phillips GJ, et al. The altered schaedler flora: continued applications of a defined murine microbial community. ILAR J. 2015; 56: 169-178.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.